Madrigal builds on liver disease awareness campaigns as it awaits FDA decision on NASH drug resmetirom

Madri­gal Phar­ma­ceu­ti­cals wants peo­ple with fat­ty liv­er dis­ease to be the num­ber one fan of their liv­ers. Its new “pa­tient ser­vice an­nounce­ment,” shown first on Thurs­day in Boston be­fore the an­nu­al Liv­er Meet­ing, fol­lows one such “fan” as she goes about her day in the neigh­bor­hood.

The new video project adds to Madri­gal’s on­go­ing liv­er dis­ease aware­ness work around non­al­co­holic steato­hep­ati­tis, or NASH. Its “Tak­ing on Fat­ty Liv­er and NASH” cam­paign de­buted in the sum­mer, while its health­care pro­fes­sion­al cam­paign “NASH Ex­plored” be­gan last year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Potential Cannabis Buyouts

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

Read More »